4//SEC Filing
Proehl Investment Ventures LLC 4
Accession 0000905718-21-001108
CIK 0001853816other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 12:48 PM ET
Size
26.9 KB
Accession
0000905718-21-001108
Insider Transaction Report
Form 4
Proehl Investment Ventures LLC
10% Owner
Transactions
- Conversion
Series 1c Preferred Stock
2021-08-17−25,582,050→ 0 total→ Common Stock (1,247,904 underlying) - Conversion
Series 1 Preferred Stock
2021-08-17−1,755,622→ 0 total→ Common Stock (85,640 underlying) - Conversion
Series 1a Warrants
2021-08-17−573,750→ 0 totalFrom: 2016-11-15Exp: 2026-03-14→ Common Stock (27,987 underlying) - Conversion
Warrant to Purchase Common Stock
2021-08-17+27,987→ 27,987 totalExercise: $20.50From: 2016-11-15Exp: 2026-03-14→ Common Stock (27,987 underlying) - Conversion
Common Stock
2021-08-17+361,147→ 1,278,464 total - Conversion
Common Stock
2021-08-17+111,951→ 1,390,415 total - Conversion
Common Stock
2021-08-17+181,585→ 1,572,000 total - Conversion
Common Stock
2021-08-17+1,247,904→ 2,819,904 total - Conversion
Common Stock
2021-08-17+85,640→ 2,905,544 total - Conversion
Series 1d Preferred Stock
2021-08-17−2,436,657→ 0 total→ Common Stock (361,147 underlying) - Conversion
Series 1a Preferred Stock
2021-08-17−2,295,000→ 0 total→ Common Stock (111,951 underlying) - Conversion
Series 1b Preferred Stock
2021-08-17−3,722,500→ 0 total→ Common Stock (181,585 underlying)
Footnotes (6)
- [F1]The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
- [F2]The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
- [F3]The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
- [F4]The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
- [F5]The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
- [F6]The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.
Documents
Issuer
Dermata Therapeutics, Inc.
CIK 0001853816
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001877913
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 12:48 PM ET
- Size
- 26.9 KB